Gala Cancelled for 2020
The IN Cure of MS Gala has been cancelled for 2020. We are devastated to share this news with you, but we firmly believe it is in the best interest of those in attendance, especially those living with Multiple Sclerosis. This is not a decision we have taken lightly, and we understand the gravity of the situation for those living with MS, as this event helps fund research for Progressive Multiple Sclerosis. Though we unfortunately will not come together in person in 2020, we continue to strive towards our main purpose – to help find a cure for MS, and we will continue to fundraise while also planning for the Gala on June 18, 2021.
The evolving coronavirus pandemic continues to impact so many. Now, more than ever, people affected by MS rely on critical information, support, research pathways, and connection to remain strong and resilient throughout this crisis and beyond. The National MS Society stands to lose $60 million in vital funding due to this crisis – 1/3 of total projected revenue. That means services for people with MS are at stake; MS research is at stake; and vital advocacy is at stake. Your donation will make a difference.
IN Cure of MS was created after a group of individuals came together to make a difference for those impacted by Multiple Sclerosis. The dream was to create an event to increase awareness and raise money for MS research while having a memorable experience. In 2019, the event raised over $159,000 to help fund Progessive MS Research through the National MS Society.
At this time, we want to thank our generous and supportive sponsors who raised their hands to support our cause. Their support makes a huge difference in the fight against MS.
Gold: Gray Properties, Bill & Nancy Bastian, PK Partners, Indie Asset Partners, and Ambrose.
Silver: LeafSpring School, One68, Compass Commercial Construction, Tetragon Financial Management, Glazer, Jill Zaniker, Blue Diamond, Leader Capital, and Vantage Consulting
Bronze: Sauer Dentistry, Somerset CPAs and Advisors, Anonymous Supporter, United Healthcare, Miller Pipeline, Merrill Lynch – Al Douglas Group, and Scopelitis Garvin Light Hanson & Feary PC.